HOME >> MEDICINE >> NEWS
Experimental shingles vaccine proves effective in nationwide study

In one of the largest adult vaccine clinical trials ever, researchers have found that an experimental vaccine against shingles (zoster vaccine) prevented about half of cases of shingles--a painful nerve and skin infection--and dramatically reduced its severity and complications in vaccinated persons who got the disease. The findings appear in the June 2 issue of The New England Journal of Medicine.

The Shingles Prevention Study, conducted over 5 -years, was led by the Department of Veterans Affairs (VA) and carried out in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and Merck & Co., Inc. (Whitehouse Station, NJ).

"This is very promising news for older persons," says Stephen E. Straus, M.D., an infectious diseases specialist at NIAID and Director of the NIH National Center for Complementary and Alternative Medicine, who participated in the design, oversight and conduct of the trial. "These striking results indicate for the first time that we can use a vaccine to prevent shingles, one of the most common and debilitating illnesses of aging. And among vaccine recipients who did get shingles, the episodes generally were far milder than they otherwise would have been."

"For some people, shingles can result in months or even years of misery," comments study leader Michael N. Oxman, M.D., an infectious disease specialist at the San Diego VA Healthcare System and the University of California, San Diego.

Shingles, also known as herpes zoster, is caused by reactivation of the virus that causes chickenpox. Once chickenpox infection has run its course, the virus is not eliminated; rather, it retreats to clusters of sensory nerve cells usually located near the spinal cord, where the virus persists in a dormant state. As immunity weakens with advancing age, the virus can reactivate, multiply in and damage sensory nerve cells to cause pain. It then migrates
'"/>

Contact: Laurie K. Doepel
doepel@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
1-Jun-2005


Page: 1 2 3 4

Related medicine news :

1. Experimental gene therapy abolishes arthritis pain and lessens joint damage
2. Mayo Clinic research in cardiovascular disease presented at Experimental Biology 2007
3. Experimental flu vaccine appears promising in early tests
4. Experimental ragweed therapy offers allergy sufferers longer relief with fewer shots
5. Experimental medication kicks depression in hours instead of weeks
6. Experimental vaccine protects lab animals against several strains of H5N1
7. Experimental therapies and vaccines for Ebola and Marburg viruses focus of Academy meeting
8. Tai Chi boosts immunity to shingles virus in older adults, NIH-sponsored study reports
9. Antiviral drugs may help relieve nerve pain related to shingles
10. Epidural injection does not reduce long-term pain for people with shingles
11. Traditional Chinese exercises may increase efficacy of flu vaccine

Post Your Comments:
(Date:10/31/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its ... the U.S. indoor air quality (IAQ) market is expected to ... growth rate (CAGR) of 7% over the next five years. ... CAGR of 7.4%. , Since 2012, continuing media attention ... of infectious diseases such as bird flu and the increase ...
(Date:10/31/2014)... Boca Raton, FL (PRWEB) October 31, 2014 ... wellness company founded on the highest principles of patient ... Lifescript , a leading health and wellness website, to ... those living with diabetes. , The Diabetes Health ... tips and recipes for those living with diabetes. Content ...
(Date:10/31/2014)... News) -- Carving pumpkins and trick-or-treating may seem like ... emergency rooms in the United States every year, experts ... fifth highest number of ER visits involving children aged ... the National Electronic Injury Surveillance System. Nearly ... the American Academy of Orthopaedic Surgeons and the Pediatric ...
(Date:10/31/2014)... to generic hormone therapy medicines improves the chances that ... a new study found. "We know that hormone ... reduce recurrence by up to 50 percent," study leader ... Columbia University Medical Center in New York City, said ... by our group and others has shown that a ...
(Date:10/31/2014)... News) -- There are clear differences in the brains ... of healthy people, new research indicates. Scientists ... could help doctors diagnose this baffling condition and shed ... syndrome are often misdiagnosed or labeled as hypochondriacs. ... "we found that [chronic fatigue syndrome] patients, brains diverge ...
Breaking Medicine News(10 mins):Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 2Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 3Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 3Health News:Halloween at the ER Is No Treat 2Health News:Generic Drugs May Help Breast Cancer Patients Stick to Therapy 2Health News:Brain Scans Yield Clues to Chronic Fatigue Syndrome 2Health News:Brain Scans Yield Clues to Chronic Fatigue Syndrome 3
(Date:10/31/2014)... Investor-Edge has initiated coverage on the following equities: ... ABT ), Hologic Inc. (NASDAQ: HOLX ... PLC (NYSE: COV). Free research on these five companies can ... markets on Thursday, October 30, 2014, ended on a positive ... up 1.30% and the NASDAQ Composite closed at 4,566.14, up ...
(Date:10/31/2014)...  Zebra Imaging, Inc., the world,s foremost provider ... strategic partnership with the Zygote Media Group Inc., ... biomedical models for animation and visual effects, to ... maintains the world,s most comprehensive library of accurate ... development of high-end solid 3D anatomy models for ...
(Date:10/31/2014)... , Oct. 31, 2014  Australian biopharmaceutical company Specialised ... (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine, will ... patients with metastatic pancreatic cancer from 1 November. ... cancer is the 5 th most common cause ... all cancer deaths, with the lowest 5-year survival of ...
Breaking Medicine Technology:Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 2Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 3Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 4Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 5Zebra Imaging and Zygote Media Partner to Bring 3D Visualization to the Medical Community 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 3Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 4Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 5Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 6Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 7Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 8
Cached News: